Galapagos

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.

CEO

Henry O. Gosebruch

CEOHenry O. Gosebruch

Employees

704

Employees704

Headquarters

Mechelen, Brussels Region

HeadquartersMechelen, Brussels Region

Founded

1999

Founded1999

Employees

704

Employees704

GLPG Key Statistics

Market cap

2.10B

Market cap2.10B

Price-Earnings ratio

-6.76

Price-Earnings ratio-6.76

Dividend yield

—

Dividend yield—

Average volume

255.80K

Average volume255.80K

High today

$31.85

High today$31.85

Low today

$31.17

Low today$31.17

Open price

$31.22

Open price$31.22

Volume

100.56K

Volume100.56K

52 Week high

$37.78

52 Week high$37.78

52 Week low

$22.36

52 Week low$22.36

GLPG News

TipRanks 3d

Galapagos NV Strengthens Board with Strategic Appointments

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Nasdaq 4d

GLPG Crosses Above Average Analyst Target

In recent trading, shares of Galapagos NV (Symbol: GLPG) have crossed above the average analyst 12-month target price of $31.10, changing hands for $31.34/share...

Analyst ratings

40%

of 10 ratings

Buy

30%

Hold

40%

Sell

30%